Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A

Key clinical point: Mortality rates in the NSHA cohort were influenced by age, male sex, and hepatitis C and HIV infections.

Major finding: The most common primary cause of death was malignancy (20.0%).

Study details: The researchers assessed 6.624 individuals born with NSHA from the ATHNdataset.

Disclosures: Dr. Lim reported no conflicts. Other authors reported research and consulting funding from a variety of pharmaceutical and biotechnology companies.


Lim MY et al. Blood Adv. 2020;4(19):4739-47.